Shareholder information
Home / Investor relations / Shareholder information
The Board's aim is to strike a balance between the interest of the business, our financial creditors and our shareholders. Dividends will normally be paid twice a year, with a greater proportion paid as a second interm.
Upcoming events
Annual General Meeting and General Meeting information
2025
General Meeting 3 November 2025
Annual General Meeting
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
Shareholder forms (holders of Ordinary Shares)
You can download a selection of our registrar instruction forms here. If you can't find the form you require please go to the Equiniti Shareview website.
Completed forms should be returned to:
Equiniti
Aspect House
Spencer Road
Lancing
West Sussex
BN99 6DA
For more information, shareholder services and changes to personal details, visit the Equiniti website.
Tax information: Alexion
You can download a copy of Form 8937 prepared in relation to the Alexion transaction here. This form will be available on the AstraZeneca website until 31 December 2031.
Tax Information: Fusion
You can download a copy of the 2024 PFIC Annual Information Statement in relation to the Fusion transaction here. This document will be available on the AstraZeneca website until 31 December 2029.
-
Investor Relations contacts
For investor enquiries, please contact our team
-
Shareholder FAQs
Answers to frequently asked shareholder questions
-
Governance
We apply the principles of good corporate governance in the UK Corporate Governance Code and related guidance
